ArticleTranslational cancer research2026
Radiomics-based machine learning models decipher heterogeneity of anoikis-related molecular subtypes for prognostic stratification in head and neck squamous cell carcinoma.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Head and neck squamous cell carcinoma (HNSC) exhibits high molecular heterogeneity and frequent metastasis, which is strongly linked to anoikis dysregulation. This study aimed to investigate whether radiomics could offer a novel perspective for assessing the heterogeneity and risk stratification of HNSC associated with anoikis-related genes (ANRGs). Methods: A total of 118 HNSC patients with paired gene expression and imaging data were included. Radiomics features were extracted from computed tomography (CT) images using PyRadiomics. By employing consensus clustering methods, the heterogeneity of ANRGs-related HNSC was identified into different subtypes, and multi-machine learning model combinations were constructed based on radiomics features to predict the molecular subtypes. An ANRGs-related radiomics prognostic model was constructed to assess the association between subtypes and clinical outcomes. Results: Three subtypes were identified via consensus clustering of 31 prognostic ANRG expression profiles: C1, C2, and C3. Compared to other subtypes, C1 exhibited significantly worse overall survival and distinct immune infiltration levels. Of the multi-combination machine learning models, 71% demonstrated robust generalization in predicting C1 [areas under the curve (AUC) >0.75). The least absolute shrinkage and selection operator-random forest combined model achieved optimal performance, with an AUC of 0.86. The ANRGs-associated radiomics prognostic model showed significant prognostic value and was closely linked to pathways involving enhanced tumor invasiveness and immunosuppressive microenvironment. Conclusions: This study demonstrated that radiomics enables stratified prediction of ANRGs-associated HNSC heterogeneity while providing molecular annotation and prognostic evaluation for ANRGs-related radiomics features, highlighting its translational value in precision oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.